Search details
1.
Nonclinical Development of SRK-181: An Anti-Latent TGFß1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid Tumors.
Int J Toxicol
; 40(3): 226-241, 2021.
Article
in English
| MEDLINE | ID: mdl-33739172
2.
Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques.
PLoS Pathog
; 14(10): e1007305, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30312351
3.
Human and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of TCR Selection.
PLoS Pathog
; 11(5): e1004849, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25945999
4.
Selective inhibition of TGFß1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape.
Sci Transl Med
; 12(536)2020 03 25.
Article
in English
| MEDLINE | ID: mdl-32213632
5.
Digitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of Tuberculosis.
mBio
; 8(3)2017 05 09.
Article
in English
| MEDLINE | ID: mdl-28487426
6.
A bug's life in the granuloma.
Semin Immunopathol
; 38(2): 213-20, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26577238
7.
Macrophages clean up: efferocytosis and microbial control.
Curr Opin Microbiol
; 17: 17-23, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24581688
8.
Efferocytosis is an innate antibacterial mechanism.
Cell Host Microbe
; 12(3): 289-300, 2012 Sep 13.
Article
in English
| MEDLINE | ID: mdl-22980326
9.
Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis.
Microbes Infect
; 13(8-9): 749-56, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21458584
Results
1 -
9
de 9
1
Next >
>>